The Efficacy and Safety of HRS-4029 in Acute Ischemic Stroke Patients

NCT07739160 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

340

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Ischemic Stroke

Interventions

DRUG: HRS-4029
DRUG: Placebo

Sponsor

Beijing Suncadia Pharmaceuticals Co., Ltd